| Trial Identifier: | D589BC00018 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT03924635 |
| Start Date: | August 2019 |
| Primary Completion Date: | December 2022 |
| Study Completion Date: | December 2022 |
| Condition: | Asthma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version |
| Country | Location |
|---|---|
| GB | Bradford, GB, BD9 6RJ |
| GB | Dundee, GB, DD1 9SY |
| GB | Nottingham, GB, NG5 1PB |
| GB | Oxford, GB |
| GB | Watford, GB, WD18 0HB |
| GB | Wishaw, GB, ML2 0DP |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company